Patients with severe COVID-19 who were given plasma from people who'd recovered were more likely to stabilise or need less oxygen support than other similar hospital patients, according to the results of a small U.S. study released on Friday.
Hospitals around the world have been using plasma donated by recovered COVID-19 patients, but there has been little information on how effective the treatment is. The plasma donor is a patient who recovered from Covid-19 on May 6.
Convalescent plasma therapy involves taking antibodies from the blood of a person who has recovered from Covid-19. The plasma is then injected into an active Covid-19 patient to help kickstart the immune response. "I have recovered ... and fortunately did not have any major symptoms".More news: The Google Pixel 4a may be delayed again
However, Covid-19 convalescent plasma has not yet been approved for use by the United States (US) Food and Drug Administration and is now being regulated as an investigational product.
The man said he has been informed that his plasma would be used to treat two critically-ill patients. "He will be soon discharged from hospital", Sasoon Hospital said. "She tested negative for Covid-19 when her throat and nasal swab samples were analysed via a molecular (RT-PCR) test, 15 days after she was found positive", said Sassoon General's dean, Muralidhar Tambe.
"As of May 1, almost 13 per cent of plasma recipients had died, compared with more than 24 per cent of the control patients, with 72 per cent and 67 per cent, respectively, being discharged alive".More news: Jeff Sessions tells Trump his 'anger' over recusal won't swing Senate race
A special task force of specialist doctors, set up under the chairmanship of Dr D B Kadam, recommended tocilizumab for COVID-19 patients in case their condition worsens, he said.
The DCGI had given the nod for the trial to see if this could be a potential treatment for the infection.More news: Wesfarmers Is Converting Target Stores To Kmart Ones